Charles River Laboratories CRL DSA — D&A
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's dsa — d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's DSA — D&A?
- Charles River Laboratories (CRL) reported DSA — D&A of $39.91M in Q1 2026.
- How has Charles River Laboratories's DSA — D&A changed year-over-year?
- Charles River Laboratories's DSA — D&A decreased by 5.2% year-over-year, from $42.08M to $39.91M.
- What is the long-term trend for Charles River Laboratories's DSA — D&A?
- Over 2 years (2023 to 2025), Charles River Laboratories's DSA — D&A has grown at a -0.2% compound annual growth rate (CAGR), from $174.72M to $174.03M.
- What does DSA — D&A mean?
- The total non-cash accounting charge for the aging of equipment and the value reduction of intangible assets.
- How do you interpret DSA — D&A?
- High levels relative to capital expenditures may suggest that the segment is not replacing its asset base quickly enough.
- How does DSA — D&A compare across companies?
- Standard accounting metric for all asset-heavy businesses.